Tuesday, March 18, 2025
wellness India Expo
Home Tags ALK-positive lung cancer

Tag: ALK-positive lung cancer

Pfizer’s LORBRENA achieves 60% five-year survival in ALK-positive lung cancer

Phase 3 CROWN trial shows 81% reduction in progression risk and 94% fewer brain metastases compared to XALKORI®